Back
Limited durability of protection conferred by XBB.1.5 vaccines against Omicron-associated severe outcomes among community-dwelling adults aged >=50 years, Ontario, Canada, September 2023 to June 2024
Lee, N.; Nguygen, L.; Nasreen, S.; Austin, P. C.; Brown, K. A.; Buchan, S. A.; Grewal, R.; Schwartz, K. L.; Tadrous, M.; Wilson, K.; Wilson, S. E.; Kwong, J. C.
2024-12-16
infectious diseases
10.1101/2024.12.14.24318807
medRxiv
Show abstract
We estimated XBB.1.5 vaccine effectiveness against hospitalization/death among adults aged [≥]50 years. Compared with non-XBB.1.5 vaccinees, the initial protection of 64% (95%CI, 57%-69%) was reduced when JN/KP-sublineages became predominant, and quickly declined. No significant protection was observed >6 months post-vaccination. Short durability of protection poses unique challenges for COVID-19 vaccination.
Matching journals
●Non-profit
◐University press
○Commercial
The top 3 journals account for 50% of the predicted probability mass.
1
The Lancet Infectious Diseases
○
71 papers in training set
Top 0.1%
34.1%
2
Nature Communications
○
4913 papers in training set
Top 16%
10.4%
3
Nature Medicine
○
117 papers in training set
Top 0.2%
7.4%
50% of probability mass above
4
PLOS Medicine
●
98 papers in training set
Top 0.3%
7.0%
5
Clinical Infectious Diseases
◐
231 papers in training set
Top 0.7%
6.6%
6
Science
●
429 papers in training set
Top 10%
3.2%
7
Nature
○
575 papers in training set
Top 10%
1.8%
8
Vaccine
○
189 papers in training set
Top 1%
1.7%
9
International Journal of Infectious Diseases
○
126 papers in training set
Top 1%
1.7%
10
Science Translational Medicine
●
111 papers in training set
Top 3%
1.5%
11
The Lancet Respiratory Medicine
○
17 papers in training set
Top 0.1%
1.4%
12
New England Journal of Medicine
●
50 papers in training set
Top 0.5%
1.4%
13
eLife
●
5422 papers in training set
Top 46%
1.4%
14
Journal of Infection
○
71 papers in training set
Top 2%
1.3%
15
Annals of Internal Medicine
●
27 papers in training set
Top 0.8%
0.8%
16
JAMA Network Open
●
127 papers in training set
Top 4%
0.8%
17
Cell Reports Medicine
○
140 papers in training set
Top 7%
0.8%
18
Cell
○
370 papers in training set
Top 16%
0.8%
19
Eurosurveillance
●
80 papers in training set
Top 1%
0.8%
20
Emerging Infectious Diseases
●
103 papers in training set
Top 3%
0.7%
21
BMC Medicine
○
163 papers in training set
Top 7%
0.7%
22
Vaccines
○
196 papers in training set
Top 3%
0.7%
23
Nature Immunology
○
71 papers in training set
Top 2%
0.5%
24
BMJ
●
49 papers in training set
Top 1%
0.5%
25
Journal of Clinical Investigation
●
164 papers in training set
Top 8%
0.5%
26
eBioMedicine
○
130 papers in training set
Top 6%
0.5%